WillScot Announces Investor Conference Schedule for September 2026
Get Alerts WSC Hot Sheet
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 1.4%
Revenue Growth %: +2.8%
Join SI Premium – FREE
SCOTTSDALE, Ariz., Sept. 15, 2026 (GLOBE NEWSWIRE) -- WillScot Holdings Corporation (“WillScot” or the “Company”) (Nasdaq: WSC), a leader in innovative temporary flexible space solutions, today announced that it will participate in the following investor conferences over the upcoming weeks:
- D.A. Davidson Diversified Industrials & Services Conference
Date: September 24, 2026
Location: Nashville, Tennessee
- Deutsche Bank Leveraged Finance Conference
Date: September 29, 2026
Location: Scottsdale, Arizona
Portfolio managers and analysts who wish to request a meeting should contact their sales representative at the sponsoring firms.
About WillScot
WillScot (Nasdaq: WSC) is a leading provider of innovative turnkey space solutions in North America, helping customers keep projects moving and operations running. The Company partners with critical industries including construction, manufacturing, healthcare, government, energy and education to deliver the right solutions coupled with a high level of customer service. WillScot’s comprehensive portfolio of products – including modular complexes, dry and cold storage containers, blast-resistant buildings, clearspan industrial structures, fencing, and add-on furnishings and equipment – is customizable and flexible to support any project need. Headquartered in Scottsdale, Ariz., WillScot operates from a network of approximately 240 branch locations in the U.S., Canada, and Mexico.
Additional information can be found on the company's website at www.willscot.com.
Contact Information
Investor inquiries:
Charlie Wohlhuter
[email protected]
Media inquiries:
Juliana Welling
[email protected]
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ADARx Pharmaceuticals Announces Pricing of Upsized $446.3 Million Initial Public Offering
- New Paper Offers Practical Roadmap for Using Real-World Data in FDA Drug Approvals and Label Expansions
- REGENXBIO Presents Positive Three-Year Durability Data for Surabgene Lomparvovec in Diabetic Retinopathy at Retina Society Annual Scientific Meeting
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesRelated Entities
Deutsche Bank, D.A. DavidsonSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share